A retrospective study of propranolol therapy in 635 infants with infantile hemangioma

Pediatr Dermatol. 2015 Jan-Feb;32(1):151-2. doi: 10.1111/pde.12308. Epub 2014 Mar 6.

Abstract

Six hundred thirty-five patients underwent oral propranolol treatment for infantile hemangioma. The efficacy rate was 91.2% and 162 of the patients recovered completely. No significant adverse effects were observed and the overall incidence of adverse effects was 2.1%.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists / therapeutic use*
  • Child, Preschool
  • Female
  • Hemangioma / drug therapy*
  • Hemangioma / pathology
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Propranolol / therapeutic use*
  • Retrospective Studies
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Adrenergic beta-Antagonists
  • Propranolol